National experience with Nintedanib for restrictive allograft syndrome following lung transplantation
H. Schultz (Copenhagen, Denmark), E. Bendstrup (Aarhus, Denmark), K. Jensen (Copenhagen, Denmark), J. Davidsen (Odense, Denmark), T. Lund (Copenhagen, Denmark), M. Perch (Copenhagen, Denmark)
Source: International Congress 2022 – Lung allograft dysfunction: towards better monitoring and treatment
  
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Schultz (Copenhagen, Denmark), E. Bendstrup (Aarhus, Denmark), K. Jensen (Copenhagen, Denmark), J. Davidsen (Odense, Denmark), T. Lund (Copenhagen, Denmark), M. Perch (Copenhagen, Denmark). National experience with Nintedanib for restrictive allograft syndrome following lung transplantation. 691
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|